Bowel (colorectal) cancer, Colon cancer, Rectal cancer
Results
Phase 3
This trial compared capecitabine and bevacizumab with capecitabine alone for bowel (colorectal) cancer. It was for people whose cancer was thought to have a high risk of spreading to another part of the body.
Recruitment start: 12 April 2005
Recruitment end: 30 September 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Kerr
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Roche
University of Oxford
Australasian Gastro-Intestinal Trials Group (AGITG)
This is Cancer Research UK trial number CRUKE/02/017.
Last reviewed: 11 January 2017
CRUK internal database number: 403
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
